Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-16-015008
Filing Date
2016-03-18
Accepted
2016-03-17 18:17:43
Documents
4
Effectiveness Date
2016-03-18

Document Format Files

Seq Description Document Type Size
1 S-8 cdtx-s8_20160317.htm S-8 115428
2 EX-5.1 OPINION OF COOLEY LLP cdtx-ex51_120.htm EX-5.1 9886
3 EX-23.1 - CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM cdtx-ex231_7.htm EX-23.1 2932
4 GRAPHIC g2016031719304239312719.jpg GRAPHIC 5698
  Complete submission text file 0001564590-16-015008.txt   137299
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-210263 | Film No.: 161513598
SIC: 2836 Biological Products, (No Diagnostic Substances)